Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 160,023 | 130,747 | 117,012 | 169,850 | 155,927 |
| Receivables | 257,991 | 275,024 | 274,504 | 239,998 | 220,630 |
| Inventories | 89,043 | 92,695 | 92,621 | 91,674 | 89,396 |
| Other current assets | 45,297 | 107,553 | 108,565 | 89,136 | 86,597 |
| TOTAL | $579,254 | $606,019 | $592,702 | $590,658 | $552,550 |
| Non-Current Assets | |||||
| PPE Net | 676,797 | 671,244 | 687,664 | 665,609 | 676,182 |
| Intangibles | 338,551 | 456,901 | 478,274 | 309,772 | 315,238 |
| Other Non-Current Assets | 275,976 | 108,194 | 104,822 | 85,724 | 88,786 |
| TOTAL | $1,291,324 | $1,236,339 | $1,270,760 | $1,061,105 | $1,080,206 |
| Total Assets | $1,870,578 | $1,842,358 | $1,863,462 | $1,651,763 | $1,632,756 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 31,904 | 31,917 | 31,932 | 26,683 | 21,437 |
| Accounts payable and accrued liabilities | 33,815 | 27,547 | 35,218 | 35,253 | 31,770 |
| Accrued Expenses | 138,949 | 139,132 | 126,686 | 111,359 | 115,173 |
| Other current liabilities | 9,595 | 15,508 | 13,761 | 9,855 | 22,546 |
| TOTAL | $294,686 | $283,083 | $271,648 | $239,319 | $247,034 |
| Non-Current Liabilities | |||||
| Long Term Debt | 740,557 | 754,799 | 781,617 | 614,129 | 642,352 |
| Deferred Revenues | 78,124 | 66,920 | 61,870 | 54,422 | 54,177 |
| Other Non-Current Liabilities | 135,815 | 130,329 | 134,507 | 99,508 | 98,948 |
| TOTAL | $899,965 | $885,444 | $916,676 | $713,763 | $741,645 |
| Total Liabilities | $1,194,651 | $1,168,527 | $1,188,324 | $953,082 | $988,679 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,326 | 46,922 | 46,677 | 48,367 | 47,659 |
| Common Shares | 845 | 839 | 836 | 836 | 825 |
| Retained earnings | -138,775 | -165,941 | -197,977 | -233,241 | -265,473 |
| Other shareholders' equity | -70,783 | -14,346 | 17,682 | 3,949 | 8,570 |
| TOTAL | $675,927 | $673,831 | $675,138 | $698,681 | $644,077 |
| Total Liabilities And Equity | $1,870,578 | $1,842,358 | $1,863,462 | $1,651,763 | $1,632,756 |